A. Atkins, I. Stroescu, N. Spagnola, V. Davis, T. Patterson, M. Narasimhan, Philip D. Harvey, R. Keefe
{"title":"Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).","authors":"A. Atkins, I. Stroescu, N. Spagnola, V. Davis, T. Patterson, M. Narasimhan, Philip D. Harvey, R. Keefe","doi":"10.14283/JPAD.2015.61","DOIUrl":null,"url":null,"abstract":"Clinical trials for primary prevention and early intervention in preclinical AD require measures of functional capacity with improved sensitivity to deficits in healthier, non-demented individuals. To this end, the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) was developed as a direct performance-based assessment of functional capacity that is sensitive to changes in function across multiple populations. Using a realistic virtual reality environment, the VRFCAT assesses a subject's ability to complete instrumental activities associated with a shopping trip. The present investigation represents an initial evaluation of the VRFCAT as a potential co-primary measure of functional capacity in healthy aging and preclinical MCI/AD by examining test-retest reliability and associations with cognitive performance in healthy young and older adults. The VRFCAT was compared and contrasted with the UPSA-2-VIM, a traditional performance-based assessment utilizing physical props. Results demonstrated strong age-related differences in performance on each VRFCAT outcome measure, including total completion time, total errors, and total forced progressions. VRFCAT performance showed strong correlations with cognitive performance across both age groups. VRFCAT Total Time demonstrated good test-retest reliability (ICC=.80 in young adults; ICC=.64 in older adults) and insignificant practice effects, indicating the measure is suitable for repeated testing in healthy populations. Taken together, these results provide preliminary support for the VRFCAT as a potential measure of functionally relevant change in primary prevention and preclinical AD/MCI trials.","PeriodicalId":48606,"journal":{"name":"Jpad-Journal of Prevention of Alzheimers Disease","volume":"2 2 1","pages":"121-127"},"PeriodicalIF":8.5000,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14283/JPAD.2015.61","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jpad-Journal of Prevention of Alzheimers Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14283/JPAD.2015.61","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 20
Abstract
Clinical trials for primary prevention and early intervention in preclinical AD require measures of functional capacity with improved sensitivity to deficits in healthier, non-demented individuals. To this end, the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) was developed as a direct performance-based assessment of functional capacity that is sensitive to changes in function across multiple populations. Using a realistic virtual reality environment, the VRFCAT assesses a subject's ability to complete instrumental activities associated with a shopping trip. The present investigation represents an initial evaluation of the VRFCAT as a potential co-primary measure of functional capacity in healthy aging and preclinical MCI/AD by examining test-retest reliability and associations with cognitive performance in healthy young and older adults. The VRFCAT was compared and contrasted with the UPSA-2-VIM, a traditional performance-based assessment utilizing physical props. Results demonstrated strong age-related differences in performance on each VRFCAT outcome measure, including total completion time, total errors, and total forced progressions. VRFCAT performance showed strong correlations with cognitive performance across both age groups. VRFCAT Total Time demonstrated good test-retest reliability (ICC=.80 in young adults; ICC=.64 in older adults) and insignificant practice effects, indicating the measure is suitable for repeated testing in healthy populations. Taken together, these results provide preliminary support for the VRFCAT as a potential measure of functionally relevant change in primary prevention and preclinical AD/MCI trials.
临床前阿尔茨海默病的初级预防和早期干预的临床试验需要对健康、非痴呆个体的功能能力进行测量,并提高对缺陷的敏感性。为此,开发了虚拟现实功能能力评估工具(VRFCAT),作为对多个人群功能变化敏感的功能能力的直接基于性能的评估。使用逼真的虚拟现实环境,VRFCAT评估受试者完成与购物之旅相关的工具性活动的能力。本研究对VRFCAT作为健康老年人和临床前MCI/AD患者功能能力的潜在共同主要测量指标进行了初步评估,通过检查健康年轻人和老年人的重测信度及其与认知表现的关系。VRFCAT与UPSA-2-VIM进行了比较和对比,UPSA-2-VIM是一种传统的基于物理道具的绩效评估。结果显示,在每个VRFCAT结果测量中,包括总完成时间、总错误和总强制进展,表现存在强烈的年龄相关差异。VRFCAT的表现与两个年龄组的认知表现都有很强的相关性。VRFCAT Total Time表现出良好的重测信度(ICC=)。青年80例;刑事法庭=。64例老年人),实践效果不显著,表明该措施适合在健康人群中重复试验。综上所述,这些结果为VRFCAT作为初级预防和临床前AD/MCI试验中功能相关变化的潜在衡量标准提供了初步支持。
期刊介绍:
The JPAD « Journal of Prevention of Alzheimer’Disease » will publish reviews, original research articles and short reports to improve our knowledge in the field of Alzheimer prevention including : neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trials design, and heath economic outcomes.
JPAD will publish also the meeting abstracts from Clinical Trial on Alzheimer Disease (CTAD) and will be distributed both in paper and online version worldwide.